SAM
FLNA

Shell Asset Management’s Filana Therapeutics FLNA Stock Holding History

Shell Asset Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,611
Closed -$67K – 1400
2022
Q3 		$67K Sell
1,611
-213
-12% -$5.75K ﹤0.01% 1298
2022
Q2 		$51K Buy
1,824
+27
+2% +$682 ﹤0.01% 1354
2022
Q1 		$67K Sell
1,797
-267
-13% -$11.3K ﹤0.01% 1331
2021
Q4 		$90K Sell
2,064
-42
-2% -$2.2K ﹤0.01% 1336
2021
Q3 		$131K Sell
2,106
-80
-4% -$6.68K ﹤0.01% 1277
2021
Q2 		$187K Buy
+2,186
New +$117K ﹤0.01% 1247

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Shell Asset Management's FLNA Position: Q4 2022 in Review

Shell Asset Management sold out of Filana Therapeutics (FLNA) in Q4 2022, closing a stake of 1,611 shares — an estimated $67K sold.

Shell Asset Management first reported a position in FLNA in Q2 2021 and held it in 6 quarters. The position peaked at $187K in Q2 2021. 153 funds tracked by Wall St. Rank hold FLNA as of Q4 2022.

  • Shell Asset Management reported no remaining Filana Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Shell Asset Management sold 1,611 Filana Therapeutics shares in Q4 2022, an estimated $67K.
  • Shell Asset Management first reported a position in Filana Therapeutics in Q2 2021 and held it in 6 quarters.
  • Shell Asset Management's Filana Therapeutics position peaked at $187K in Q2 2021.
  • 153 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2022.

Based on Shell Asset Management's 13F filing for Q4 2022, filed 7 Feb 2023.